| 000 | 01816 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513143405.0 | ||
| 264 | 0 | _c19980603 | |
| 008 | 199806s 0 0 eng d | ||
| 022 | _a0014-2980 | ||
| 024 | 7 |
_a10.1002/(SICI)1521-4141(199805)28:05<1719::AID-IMMU1719>3.0.CO;2-Q _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aClarke, C J | |
| 245 | 0 | 0 |
_aIL-10-mediated suppression of TNF-alpha production is independent of its ability to inhibit NF kappa B activity. _h[electronic resource] |
| 260 |
_bEuropean journal of immunology _cMay 1998 |
||
| 300 |
_a1719-26 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBiological Transport |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCell Nucleus _xmetabolism |
| 650 | 0 | 4 |
_aDNA _ximmunology |
| 650 | 0 | 4 |
_aDNA-Binding Proteins _xmetabolism |
| 650 | 0 | 4 | _aI-kappa B Proteins |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacology |
| 650 | 0 | 4 |
_aInterleukin-10 _xphysiology |
| 650 | 0 | 4 |
_aInterleukin-4 _xphysiology |
| 650 | 0 | 4 |
_aLipopolysaccharides _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aMacrophages _xmetabolism |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aNF-KappaB Inhibitor alpha |
| 650 | 0 | 4 |
_aNF-kappa B _xantagonists & inhibitors |
| 650 | 0 | 4 | _aNF-kappa B p50 Subunit |
| 650 | 0 | 4 |
_aProtein Binding _ximmunology |
| 650 | 0 | 4 |
_aRNA, Messenger _xdrug effects |
| 650 | 0 | 4 | _aTranscription Factor RelA |
| 650 | 0 | 4 |
_aTranscription, Genetic _xdrug effects |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aHales, A | |
| 700 | 1 | _aHunt, A | |
| 700 | 1 | _aFoxwell, B M | |
| 773 | 0 |
_tEuropean journal of immunology _gvol. 28 _gno. 5 _gp. 1719-26 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/(SICI)1521-4141(199805)28:05<1719::AID-IMMU1719>3.0.CO;2-Q _zAvailable from publisher's website |
| 999 |
_c9570178 _d9570178 |
||